252 related articles for article (PubMed ID: 35947632)
1. Bee venom-loaded EGFR-targeting peptide-coupled chitosan nanoparticles for effective therapy of hepatocellular carcinoma by inhibiting EGFR-mediated MEK/ERK pathway.
Abdulmalek S; Mostafa N; Gomaa M; El-Kersh M; Elkady AI; Balbaa M
PLoS One; 2022; 17(8):e0272776. PubMed ID: 35947632
[TBL] [Abstract][Full Text] [Related]
2. GE11 peptide conjugated selenium nanoparticles for EGFR targeted oridonin delivery to achieve enhanced anticancer efficacy by inhibiting EGFR-mediated PI3K/AKT and Ras/Raf/MEK/ERK pathways.
Pi J; Jiang J; Cai H; Yang F; Jin H; Yang P; Cai J; Chen ZW
Drug Deliv; 2017 Nov; 24(1):1549-1564. PubMed ID: 29019267
[TBL] [Abstract][Full Text] [Related]
3. Functionalized siRNA-chitosan nanoformulations promote triple-negative breast cancer cell death via blocking the miRNA-21/AKT/ERK signaling axis: in-silico and in vitro studies.
Abdulmalek SA; Saleh AM; Shahin YR; El Azab EF
Naunyn Schmiedebergs Arch Pharmacol; 2024 Apr; ():. PubMed ID: 38592437
[TBL] [Abstract][Full Text] [Related]
4. Retraction: Bee venom-loaded EGFR-targeting peptide-coupled chitosan nanoparticles for effective therapy of hepatocellular carcinoma by inhibiting EGFR-mediated MEK/ERK pathway.
PLOS ONE Editors
PLoS One; 2023; 18(6):e0287805. PubMed ID: 37352224
[No Abstract] [Full Text] [Related]
5. GE11 peptide-installed chimaeric polymersomes tailor-made for high-efficiency EGFR-targeted protein therapy of orthotopic hepatocellular carcinoma.
Zhou C; Xia Y; Wei Y; Cheng L; Wei J; Guo B; Meng F; Cao S; van Hest JCM; Zhong Z
Acta Biomater; 2020 Sep; 113():512-521. PubMed ID: 32562803
[TBL] [Abstract][Full Text] [Related]
6. EGFR-targeted multifunctional polymersomal doxorubicin induces selective and potent suppression of orthotopic human liver cancer in vivo.
Fang Y; Yang W; Cheng L; Meng F; Zhang J; Zhong Z
Acta Biomater; 2017 Dec; 64():323-333. PubMed ID: 29030307
[TBL] [Abstract][Full Text] [Related]
7. Bee Venom Components as Therapeutic Tools against Prostate Cancer.
Badawi JK
Toxins (Basel); 2021 May; 13(5):. PubMed ID: 34067049
[TBL] [Abstract][Full Text] [Related]
8. Application of Paclitaxel-loaded EGFR Peptide-conjugated Magnetic Polymeric Liposomes for Liver Cancer Therapy.
Lin ZL; Ding J; Sun GP; Li D; He SS; Liang XF; Huang XR; Xie J
Curr Med Sci; 2020 Feb; 40(1):145-154. PubMed ID: 32166677
[TBL] [Abstract][Full Text] [Related]
9. The activation of MEK/ERK signaling pathway by bone morphogenetic protein 4 to increase hepatocellular carcinoma cell proliferation and migration.
Chiu CY; Kuo KK; Kuo TL; Lee KT; Cheng KH
Mol Cancer Res; 2012 Mar; 10(3):415-27. PubMed ID: 22241220
[TBL] [Abstract][Full Text] [Related]
10. Cyclosporin A activates human hepatocellular carcinoma (HepG2 cells) proliferation: implication of EGFR-mediated ERK1/2 signaling pathway.
Abo-El Fetoh ME; Helal GK; Saleh IG; Ewees M; ElShafey M; Elnagar MR; Akool ES
Naunyn Schmiedebergs Arch Pharmacol; 2020 May; 393(5):897-908. PubMed ID: 31907582
[TBL] [Abstract][Full Text] [Related]
11. Non-toxic dose of liposomal honokiol suppresses metastasis of hepatocellular carcinoma through destabilizing EGFR and inhibiting the downstream pathways.
Yang J; Pei H; Luo H; Fu A; Yang H; Hu J; Zhao C; Chai L; Chen X; Shao X; Wang C; Wu W; Wan L; Ye H; Qiu Q; Peng A; Wei Y; Yang L; Chen L
Oncotarget; 2017 Jan; 8(1):915-932. PubMed ID: 27906672
[TBL] [Abstract][Full Text] [Related]
12. An Updated Review Summarizing the Anticancer Efficacy of Melittin from Bee Venom in Several Models of Human Cancers.
Pandey P; Khan F; Khan MA; Kumar R; Upadhyay TK
Nutrients; 2023 Jul; 15(14):. PubMed ID: 37513529
[TBL] [Abstract][Full Text] [Related]
13. Polo-like Kinase 1-targeting Chitosan Nanoparticles Suppress the Progression of Hepatocellular Carcinoma.
Wang D; Chang R; Wang G; Hu B; Qiang Y; Chen Z
Anticancer Agents Med Chem; 2017; 17(7):948-954. PubMed ID: 27671301
[TBL] [Abstract][Full Text] [Related]
14. EGFR signaling confers resistance to BET inhibition in hepatocellular carcinoma through stabilizing oncogenic MYC.
Yin Y; Sun M; Zhan X; Wu C; Geng P; Sun X; Wu Y; Zhang S; Qin J; Zhuang Z; Liu Y
J Exp Clin Cancer Res; 2019 Feb; 38(1):83. PubMed ID: 30770740
[TBL] [Abstract][Full Text] [Related]
15. Targeted doxorubicin delivery and release within breast cancer environment using PEGylated chitosan nanoparticles labeled with monoclonal antibodies.
Helmi O; Elshishiny F; Mamdouh W
Int J Biol Macromol; 2021 Aug; 184():325-338. PubMed ID: 34119547
[TBL] [Abstract][Full Text] [Related]
16. Bee venom suppresses PMA-mediated MMP-9 gene activation via JNK/p38 and NF-kappaB-dependent mechanisms.
Cho HJ; Jeong YJ; Park KK; Park YY; Chung IK; Lee KG; Yeo JH; Han SM; Bae YS; Chang YC
J Ethnopharmacol; 2010 Feb; 127(3):662-8. PubMed ID: 19969058
[TBL] [Abstract][Full Text] [Related]
17. Correlation of gene expression of ATP-binding cassette protein and tyrosine kinase signaling pathway in patients with hepatocellular carcinoma.
Hoffmann K; Shibo L; Xiao Z; Longerich T; Büchler MW; Schemmer P
Anticancer Res; 2011 Nov; 31(11):3883-90. PubMed ID: 22110214
[TBL] [Abstract][Full Text] [Related]
18. The 14-3-3σ protein promotes HCC anoikis resistance by inhibiting EGFR degradation and thereby activating the EGFR-dependent ERK1/2 signaling pathway.
Song J; Liu Y; Liu F; Zhang L; Li G; Yuan C; Yu C; Lu X; Liu Q; Chen X; Liang H; Ding Z; Zhang B
Theranostics; 2021; 11(3):996-1015. PubMed ID: 33391517
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and characterization of proanthocyanidin-chitosan nanoparticles: An assessment on human colorectal carcinoma HT-29 cells.
Mani S; Balasubramanian B; Balasubramani R; Chang SW; Ponnusamy P; Esmail GA; Arasu MV; Al-Dhabi NA; Duraipandiyan V
J Photochem Photobiol B; 2020 Sep; 210():111966. PubMed ID: 32711334
[TBL] [Abstract][Full Text] [Related]
20. EGF/EGFR Promotes Salivary Adenoid Cystic Carcinoma Cell Malignant Neural Invasion
Ren Y; Hong Y; He W; Liu Y; Chen W; Wen S; Sun M
Curr Cancer Drug Targets; 2022; 22(7):603-616. PubMed ID: 35410600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]